KYORIN Holdings, Inc. (4569.T)
JPY 1440.0
(-0.89%)
JPY 1440.0
(-0.89%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 7.06 Billion JPY | 274.93% |
| 2022 | 1.88 Billion JPY | 135.07% |
| 2021 | -5.37 Billion JPY | 3.47% |
| 2020 | -5.56 Billion JPY | 33.23% |
| 2019 | -8.33 Billion JPY | -4.35% |
| 2018 | -7.98 Billion JPY | 79.39% |
| 2017 | -38.73 Billion JPY | -1.7% |
| 2016 | -38.09 Billion JPY | 3.0% |
| 2015 | -39.26 Billion JPY | -47.11% |
| 2014 | -26.69 Billion JPY | 7.15% |
| 2013 | -28.75 Billion JPY | -48.72% |
| 2012 | -19.33 Billion JPY | -7.06% |
| 2011 | -18.05 Billion JPY | -0.2% |
| 2010 | -18.02 Billion JPY | -7.92% |
| 2009 | -16.69 Billion JPY | -142.65% |
| 2008 | -6.88 Billion JPY | 13.86% |
| 2007 | -7.98 Billion JPY | 29.05% |
| 2006 | -11.25 Billion JPY | 8.94% |
| 2005 | -12.36 Billion JPY | -41.14% |
| 2004 | -8.76 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 6.68 Billion JPY | -5.25% |
| 2023 Q2 | -5.39 Billion JPY | -339.97% |
| 2023 Q3 | 1.63 Billion JPY | 130.31% |
| 2023 FY | 7.06 Billion JPY | 274.93% |
| 2023 Q1 | 2.24 Billion JPY | 19.44% |
| 2023 Q4 | 7.06 Billion JPY | 331.54% |
| 2022 Q1 | -3.33 Billion JPY | 37.97% |
| 2022 Q3 | 2.27 Billion JPY | 132.4% |
| 2022 FY | 1.88 Billion JPY | 135.07% |
| 2022 Q2 | -7.01 Billion JPY | -110.6% |
| 2022 Q4 | 1.88 Billion JPY | -17.16% |
| 2021 Q4 | -5.37 Billion JPY | 36.17% |
| 2021 Q1 | -7.4 Billion JPY | -33.15% |
| 2021 Q2 | -10.75 Billion JPY | -45.15% |
| 2021 Q3 | -8.41 Billion JPY | 21.75% |
| 2021 FY | -5.37 Billion JPY | 3.47% |
| 2020 FY | -5.56 Billion JPY | 33.23% |
| 2020 Q3 | -7.31 Billion JPY | 52.91% |
| 2020 Q4 | -5.56 Billion JPY | 23.91% |
| 2020 Q1 | -7.62 Billion JPY | 8.47% |
| 2020 Q2 | -15.52 Billion JPY | -103.57% |
| 2019 FY | -8.33 Billion JPY | -4.35% |
| 2019 Q1 | -11.34 Billion JPY | -42.05% |
| 2019 Q4 | -8.33 Billion JPY | 24.03% |
| 2019 Q2 | -19.58 Billion JPY | -72.67% |
| 2019 Q3 | -10.96 Billion JPY | 44.01% |
| 2018 Q2 | -41.94 Billion JPY | -6.54% |
| 2018 Q4 | -7.98 Billion JPY | 33.61% |
| 2018 FY | -7.98 Billion JPY | 79.39% |
| 2018 Q1 | -39.37 Billion JPY | -1.64% |
| 2018 Q3 | -12.02 Billion JPY | 71.33% |
| 2017 Q3 | -36.53 Billion JPY | 7.8% |
| 2017 FY | -38.73 Billion JPY | -1.7% |
| 2017 Q4 | -38.73 Billion JPY | -6.04% |
| 2017 Q2 | -39.61 Billion JPY | -3.44% |
| 2017 Q1 | -38.3 Billion JPY | -0.55% |
| 2016 Q4 | -38.09 Billion JPY | -5.13% |
| 2016 Q3 | -36.23 Billion JPY | 22.3% |
| 2016 Q1 | -43.06 Billion JPY | -9.66% |
| 2016 FY | -38.09 Billion JPY | 3.0% |
| 2016 Q2 | -46.62 Billion JPY | -8.28% |
| 2015 Q3 | -34.76 Billion JPY | 15.91% |
| 2015 Q4 | -39.26 Billion JPY | -12.95% |
| 2015 FY | -39.26 Billion JPY | -47.11% |
| 2015 Q1 | -34.16 Billion JPY | -28.0% |
| 2015 Q2 | -41.34 Billion JPY | -21.01% |
| 2014 Q4 | -26.69 Billion JPY | 9.01% |
| 2014 Q3 | -29.33 Billion JPY | -14.99% |
| 2014 Q1 | -26.3 Billion JPY | 8.49% |
| 2014 Q2 | -25.51 Billion JPY | 3.03% |
| 2014 FY | -26.69 Billion JPY | 7.15% |
| 2013 Q2 | -32.91 Billion JPY | -31.02% |
| 2013 Q1 | -25.12 Billion JPY | -29.95% |
| 2013 FY | -28.75 Billion JPY | -48.72% |
| 2013 Q4 | -28.75 Billion JPY | -5.02% |
| 2013 Q3 | -27.37 Billion JPY | 16.82% |
| 2012 Q3 | -20.8 Billion JPY | 26.2% |
| 2012 Q2 | -28.19 Billion JPY | -18.48% |
| 2012 Q1 | -23.79 Billion JPY | -31.79% |
| 2012 FY | -19.33 Billion JPY | -7.06% |
| 2012 Q4 | -19.33 Billion JPY | 7.09% |
| 2011 FY | -18.05 Billion JPY | -0.2% |
| 2011 Q3 | -14.93 Billion JPY | 25.05% |
| 2011 Q2 | -19.92 Billion JPY | -10.12% |
| 2011 Q1 | -18.09 Billion JPY | -0.39% |
| 2011 Q4 | -18.05 Billion JPY | -20.94% |
| 2010 Q2 | -15.08 Billion JPY | -1.72% |
| 2010 FY | -18.02 Billion JPY | -7.92% |
| 2010 Q1 | -14.83 Billion JPY | 11.18% |
| 2010 Q3 | -11.9 Billion JPY | 21.08% |
| 2010 Q4 | -18.02 Billion JPY | -51.35% |
| 2009 Q4 | -16.69 Billion JPY | -78.31% |
| 2009 Q3 | -9.36 Billion JPY | 27.7% |
| 2009 FY | -16.69 Billion JPY | -142.65% |
| 2009 Q2 | -12.95 Billion JPY | 0.0% |
| 2008 Q4 | -6.88 Billion JPY | -92.42% |
| 2008 FY | -6.88 Billion JPY | 13.86% |
| 2008 Q3 | -3.57 Billion JPY | 0.0% |
| 2007 FY | -7.98 Billion JPY | 29.05% |
| 2006 FY | -11.25 Billion JPY | 8.94% |
| 2005 FY | -12.36 Billion JPY | -41.14% |
| 2004 FY | -8.76 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.22 Billion JPY | -476.327% |
| Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 99.839% |
| Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | 98.189% |
| Shionogi & Co., Ltd. | -346.47 Billion JPY | 102.038% |
| Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | 298.085% |
| Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | 116.747% |
| Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | 111.485% |
| Eisai Co., Ltd. | -97.93 Billion JPY | 107.209% |
| Morishita Jintan Co., Ltd. | -667 Million JPY | 1158.471% |
| Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | 113.624% |
| Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | 121.445% |
| Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | 7.13% |
| Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | 9.266% |
| Tsumura & Co. | 1.61 Billion JPY | -337.152% |
| Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | 115.987% |
| Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | 120.501% |
| Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | 95.912% |
| Fuji Pharma Co., Ltd. | 26.62 Billion JPY | 73.483% |
| Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | 75.64% |
| Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | -902.841% |
| Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | -17.824% |
| SymBio Pharmaceuticals Limited | -6.51 Billion JPY | 208.332% |
| MedRx Co., Ltd | -1.72 Billion JPY | 510.465% |
| Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | 180.996% |
| Solasia Pharma K.K. | -668 Million JPY | 1156.886% |
| Modalis Therapeutics Corporation | -1.47 Billion JPY | 579.966% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | 197.339% |
| Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | 87.509% |
| Cyfuse Biomedical K.K. | -2.96 Billion JPY | 338.451% |
| Toho Holdings Co., Ltd. | -98.42 Billion JPY | 107.173% |
| Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | 163.434% |